Julien Meissonnier

Title: Julien Meissonnier: Innovator in Pharmaceutical Formulations

Introduction

Julien Meissonnier, a talented inventor based in Souffelweyersheim, France, has made significant contributions to the field of pharmaceutical formulations. His innovative work focuses on creating effective methods for the oral delivery of compounds that typically exhibit poor permeability, thereby enhancing therapeutic effectiveness.

Latest Patents

Julien holds a noteworthy patent titled "Formulation for oral delivery of proteins, peptides, and small molecules with poor permeability." This invention is designed to facilitate the oral delivery of synthetic or natural poorly permeable molecules or their salts/solvates, which possess therapeutic activity. The formulation can include poorly permeable molecules at a concentration of 0.01-10 wt. % of the total weight. Furthermore, it comprises a lipophilic phase containing triglycerides of fatty acids in an amount ranging from 50-80 wt. %, along with at least one lipophilic surfactant, such as partial esters of polyol and fatty acids, making up about 10-50 wt. % of the total weight.

Career Highlights

Throughout his career, Julien has worked for reputable companies in the pharmaceutical industry, including R.P. Scherer Technologies, Inc. and Catalent Pharma Solutions, LLC. His experience in these organizations has honed his skills and expertise in developing innovative pharmaceutical solutions.

Collaborations

Julien has collaborated with distinguished colleagues, including Vincent Plassat and Benoit Hilbold. These collaborations have likely contributed to his success, allowing for the exchange of ideas and advancements within the field of pharmacological research.

Conclusion

Julien Meissonnier stands out as an inspiring inventor whose work addresses critical challenges in drug delivery. His patent on enhancing oral delivery systems for poorly permeable molecules reflects his commitment to improving therapeutic outcomes. As innovations in pharmaceutical formulations continue to evolve, Julien’s contributions will undoubtedly influence future advancements.